D. Uzundal Et Al. , "Prognostic importance of GRIM score on sorafenib side effects, hospitalization and survival in hepatocellular cancer patients," Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) , Barcelona, Spain, 2023
Uzundal, D. Et Al. 2023. Prognostic importance of GRIM score on sorafenib side effects, hospitalization and survival in hepatocellular cancer patients. Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) , (Barcelona, Spain).
Uzundal, D., YAZICI, O., ULAŞ KAHYA, B., ÜNER, A., ÖZET, A., & ÖZDEMİR, N., (2023). Prognostic importance of GRIM score on sorafenib side effects, hospitalization and survival in hepatocellular cancer patients . Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain
Uzundal, DUYGU Et Al. "Prognostic importance of GRIM score on sorafenib side effects, hospitalization and survival in hepatocellular cancer patients," Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 2023
Uzundal, DUYGU E. Et Al. "Prognostic importance of GRIM score on sorafenib side effects, hospitalization and survival in hepatocellular cancer patients." Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) , Barcelona, Spain, 2023
Uzundal, D. Et Al. (2023) . "Prognostic importance of GRIM score on sorafenib side effects, hospitalization and survival in hepatocellular cancer patients." Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) , Barcelona, Spain.
@conferencepaper{conferencepaper, author={DUYGU ERCAN UZUNDAL Et Al. }, title={Prognostic importance of GRIM score on sorafenib side effects, hospitalization and survival in hepatocellular cancer patients}, congress name={Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)}, city={Barcelona}, country={Spain}, year={2023}}